Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PATTI, Angelo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.581
EU - Europa 3.811
AS - Asia 2.764
SA - Sud America 451
AF - Africa 78
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.514
IT - Italia 1.225
SG - Singapore 1.042
RU - Federazione Russa 862
CN - Cina 670
DE - Germania 359
FI - Finlandia 355
BR - Brasile 349
VN - Vietnam 265
HK - Hong Kong 263
PL - Polonia 198
GB - Regno Unito 159
FR - Francia 151
UA - Ucraina 146
JP - Giappone 107
IE - Irlanda 104
IN - India 70
SE - Svezia 63
KR - Corea 61
RO - Romania 36
BD - Bangladesh 34
IQ - Iraq 33
TR - Turchia 30
AR - Argentina 29
AT - Austria 29
CA - Canada 29
MX - Messico 28
IR - Iran 27
BE - Belgio 23
CI - Costa d'Avorio 20
ES - Italia 19
PK - Pakistan 19
MY - Malesia 18
TH - Thailandia 18
UZ - Uzbekistan 17
ZA - Sudafrica 17
NL - Olanda 15
AU - Australia 14
CL - Cile 14
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
VE - Venezuela 13
CO - Colombia 11
NP - Nepal 10
CH - Svizzera 9
EC - Ecuador 9
GR - Grecia 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
ID - Indonesia 8
IL - Israele 8
KE - Kenya 8
BG - Bulgaria 7
BO - Bolivia 7
MA - Marocco 7
DK - Danimarca 6
EG - Egitto 6
PE - Perù 6
PY - Paraguay 6
JO - Giordania 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
LT - Lituania 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
GY - Guiana 3
TN - Tunisia 3
TW - Taiwan 3
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
HU - Ungheria 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
Totale 12.698
Salva come PNG Salva come JPEG
Città #
Singapore 731
Ashburn 702
Fairfield 556
Chandler 406
San Jose 275
Wilmington 255
Woodbridge 251
Hong Kong 250
Houston 222
Seattle 220
Cambridge 184
Ann Arbor 164
Zgierz 163
Palermo 145
Moscow 144
Council Bluffs 133
Beijing 121
Des Moines 109
Medford 108
Tokyo 104
Dublin 103
Rome 103
Santa Clara 90
Los Angeles 88
Ho Chi Minh City 83
New York 82
Jacksonville 77
Lauterbourg 72
Dallas 69
Princeton 68
Altamura 67
Nanjing 67
Frankfurt am Main 65
Milan 65
Helsinki 59
Hanoi 54
Lawrence 51
The Dalles 41
San Diego 38
São Paulo 35
Boardman 33
Chicago 33
Hefei 33
Buffalo 31
Jinan 30
Tulsa 26
Changsha 25
Dearborn 25
London 25
Warsaw 25
Nuremberg 24
Shenyang 24
Da Nang 22
Nanchang 22
Orem 22
Abidjan 20
Brussels 20
Tianjin 20
Hebei 19
Bangkok 18
Redwood City 18
Baghdad 17
Guangzhou 17
Munich 17
Ningbo 17
Columbus 16
Florence 16
Ludwigshafen am Rhein 16
Rio de Janeiro 16
Tehran 16
Poplar 14
Amsterdam 13
Atlanta 13
Boston 13
Chennai 13
Denver 13
Haiphong 13
Johannesburg 13
Naples 13
Phoenix 13
Jiaxing 12
Verona 12
Bari 11
Napoli 11
San Paolo di Civitate 11
Cardiff 10
Catania 10
Falls Church 10
Melbourne 10
Montreal 10
Paris 10
Stockholm 10
Vienna 10
Brno 9
Brooklyn 9
Cagliari 9
Kuala Lumpur 9
Kumar 9
Manchester 9
Pisa 9
Totale 7.614
Salva come PNG Salva come JPEG
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 835
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 301
Autoimmune liver disease in a sicilian woman. 282
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 251
The Role of Nutraceuticals in Statin Intolerant Patients 243
REPORT OF A CASE OF MALIGNANT TUMOR-LIKE GASTRIC LESION BY CANDIDA IN A DIABETIC TREATED WITH CYCLOSPORINE FOR PSORIASIS AND REVIEW OF THE LITERATURE 242
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 241
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 230
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 219
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 217
Osteodystrophy in chronic liver diseases. 215
Diagnostica non invasiva delle varici esofagee nei pazienti con cirrosi epatica: dati ecografici vs dati endoscopici 214
Lichen sclerosus as a cause of recurrent cystitis: case report and review of the literatury. 214
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 214
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 211
Management of Statin Intolerance in 2018: Still More Questions Than Answers 211
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 210
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 197
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 197
Cloni di carciofo "Romanesco" in coltura annuale in Sicilia 195
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 190
The effect of bergamot on dyslipidemia 190
Food hypersensitivity-associated irritable bowel syndrome: may fecal assays improve diagnosis? 189
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 185
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 184
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 184
MALIGNANT TUMOR-LIKE GAASTRIC LESION DUE TO CANDIDA ALBICANS IN A DIABETIC PATIENT TREATED WITH CYCLOSPORIN: A CASE REPORT AND REVIEW OF THE LITERATURE 180
O- Alkylation of a lignite humic acid by phase-transfer catalysis 177
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 173
Improving diagnostic accuracy in Celiac Disease diagnosis: anti-endomysium antibody assay in colture medium of duodenal biopsies. 173
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect 169
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 168
Improving diagnostic accuracy in celiac disease diagnosis: antiendomysium antibody assay in the culture medium of duodenal biopsies. 167
Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion. 164
Malignant tumor-like gastric lesion by Candida albicans. 164
Food hypersensitivity in patients with irritable bowel syndrome: the diagnostic role of fecal assays. 164
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 162
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 162
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 159
Nutraceuticals as an important part of combination therapy in dyslipidaemia 157
Lichen sclerosus and atrophicus: report of a case of female patient affected with recurrent cystitis. 153
Prevalence of antibodies anti-bartonella henselae in western Sicily: children, blood donors, cats 147
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 147
Advances in pharmacological treatment of type 1 diabetes during pregnancy 147
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 145
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 144
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 143
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica 143
Anti-atherogenic Effects of 17β-Estradiol 142
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 142
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 140
Smoking and small, dense low-density lipoproteins. 139
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 137
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 132
Natural approaches in metabolic syndrome management 125
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 119
PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS 114
Metabolic disorders during pregnancy and postpartum cardiometabolic risk 114
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 112
Future perspectives of the pharmacological management of diabetic dyslipidemia 110
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 107
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 107
Novel therapeutical approaches to managing atherosclerotic risk 107
NUOVE STRATEGIE PER IL MANAGEMENT CLINICO, DIAGNOSTICO E TERAPEUTICO DELLE MALATTIE CARDIO-METABOLICHE 99
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 98
Pharmacotherapy for gestational diabetes 97
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 94
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 94
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 92
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 88
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 86
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies 81
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives 79
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 77
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 70
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 70
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 64
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 63
Obesity and HFpEF 62
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 61
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? 51
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance 49
Impact of different hormones on the regulation of nitric oxide in diabetes 46
Totale 13.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 0 0 0 0 0 0 0 68 87
2021/2022881 51 136 40 32 23 38 35 76 92 140 66 152
2022/20231.411 135 211 30 135 126 191 126 120 151 37 91 58
2023/2024681 35 91 53 43 44 143 85 37 20 18 34 78
2024/20251.558 29 172 113 143 67 55 116 80 116 168 183 316
2025/20264.775 344 158 252 456 548 694 666 518 442 573 124 0
Totale 13.137